AZD1656 for use in the treatment of pneumonitis and/or mycorditis caused by a coronavirus

The present invention relates to AZD1656 or a pharmaceutically acceptable salt thereof, for use in the treatment of pneumonitis and/or myocarditis, which may be associated with or caused by a coronavirus infection.

Saved in:
Bibliographic Details
Main Author MARTIN, John Francis
Format Patent
LanguageEnglish
Published 10.11.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to AZD1656 or a pharmaceutically acceptable salt thereof, for use in the treatment of pneumonitis and/or myocarditis, which may be associated with or caused by a coronavirus infection.
Bibliography:Application Number: AU20210237808